This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 27/3/690    most recent 01.ATV.0000255949.51053.cev1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dietzen, D. J. Articles by Turk, J. Search for Related Content PubMed PubMed Citation Articles by Dietzen, D. J. Articles by Turk, J.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:690.)
© 2007 American Heart Association, Inc.

Thrombosis

Inhibition of 3-Hydroxy-3-Methylglutaryl Coenzyme A (HMG CoA) Reductase Blunts Factor VIIa/Tissue Factor and Prothrombinase Activities via Effects on Membrane Phosphatidylserine

Dennis J. Dietzen; Keith L. Page; Tina A. Tetzloff; Alan Bohrer; John Turk

From the Departments of Pediatrics (D.J.D., K.L.P., T.A.T.), Pathology and Immunology (D.J.D., J.T.), and Internal Medicine (A.B., J.T.), Washington University School of Medicine, St. Louis, Mo.

Correspondence to Dennis J. Dietzen, Department of Pediatrics, McDonnell Pediatrics Research Bldg 3109, 4905 Parkview Place, St. Louis, MO 63110. E-mail dietzen_d{at}kids.wustl.edu

Objective— 3-Hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors (statins) exhibit antithrombotic properties that are independent of reductions in circulating LDL cholesterol. We hypothesized that these antithrombotic properties are mediated by membrane alterations secondary to disrupted lipid metabolism.

Methods and Results— EA.hy926 cells were incubated in the presence of 1 µmol/L atorvastatin supplemented with fetal bovine serum or lipid-depleted serum mixtures. Lipid restriction alone had no effect on cell lipid composition but when atorvastatin was included, phosphatidylserine, sphingomyelin, and cholesterol were reduced by 50% while ceramide content decreased by 70%. These changes in lipid composition did not alter the association of decay accelerating factor or tissue factor with lipid rafts. Atorvastatin in combination with lipid restriction reduced factor VIIa/tissue factor activity by as much as 75% but did not alter tissue factor expression. Prothrombinase activity was reduced to an extent similar to factor VIIa/tissue factor. Mevalonic acid but not LDL reversed the observed changes in lipid content and prothrombinase activity induced by atorvastatin. These findings were confirmed in primary cells.

Conclusions— Inhibition of HMG-CoA reductase limits exposure of phosphatidylserine at the cell surface by restricting the cellular pool of mevalonate-derived isoprenoids. This membrane alteration restricts the activity of proteolytic enzyme complexes that propagate the coagulation cascade.

HMG-CoA reductase inhibitors may alter coagulation via effects on phospholipid metabolism. Atorvastatin treatment of EA.hy926 cells in combination with lipid restriction reduced cell cholesterol, phosphatidylserine, sphingomyelin, and ceramide but did not alter tissue factor expression. The resulting reduction in membrane exposure of phosphatidylserine blunted factor VIIa/tissue factor and prothrombinase activities.

Key Words: Atorvastatin • phosphatidylserine • tissue factor • prothrombinase • membrane

This article has been cited by other articles:

				J. R. Hess Blood and Coagulation Support in Trauma Care Hematology, January 1, 2007; 2007(1): 187 - 191. [Abstract] [Full Text] [PDF]